|
Katushkina Yu.A., Tatarintseva Z.G., Kosmacheva E.D.
A case of severe euglycemic ketoacidosis arising during dapagliflozin intake
|
№6 / 2024
|
|
Tatarintseva Z.G., Katushkina Yu.A., Kosmacheva E.D., Babicheva O.V.
Hypokalemia in a patient with heart failure and atrial fibrillation as a predictor of life-threatening arrhythmia
|
№6 / 2024
|
|
Katushkina Yu.A., Tatarintseva Z.G., Kosmacheva E.D., Petrik G.G.
Clinical observation of a patient with primary hypoparathyroidism, uncontrolled hypocalcemia and heart failure
|
№6 / 2023
|
|
|
№3 (приложение) / 2023
|
|
|
№3 (приложение) / 2023
|
|
Demidova T.Yu., Izmailova M.Ya.
The structure of the prevalence of cardiovascular diseases and chronic kidney disease in patients with type 2 diabetes mellitus in the stationary care
|
№8 / 2022
|
|
Alieva A.M., Reznik E.V., Teplova N.V., Totolyan G.G., Gasanova E.T., Kalova M.R., Sabanchieva E.E., Nikitin I.G.
JDP2 – a new promising biological marker in cardiovascular pathology
|
№5 / 2022
|
|
Larina V.N., Larin V.G.
The place of bisoprolol cardioselective beta-adrenoblocker in treatment of patients with different chronic heart failure phenotypes
|
№1 / 2022
|
|
Alieva A.M., Teplova N.V., Kislyakov V.A., Voronkova K.V., Shnakhova L.M., Valiev R.K., Rakhaev A.M., Elmurzaeva D.A., Malkarova D.S., Nikitin I.G.
Biomarkers in cardiology: microRNA and heart failure
|
№1 / 2022
|
|
Alieva A.M., Teplova N.V., Reznik E.V., Valiev R.K., Rakhaev A.M., Kudaeva M.V., Akhmatov I.Z., Arakelyan R.A., Nikitin I.G.
Biomarkers in cardiology: lipocalin associated with neutrophil gelatinase (NGAL) and cardiovascular diseases
|
№1 / 2022
|
|
Salukhov V.V., Khalimov Yu.Sh., Cherkashin D.V., Kadin D.V.
The role of ketonemia induced by sodium-glucose cotransporter 2 inhibitors: from the energy exchange to cardioprotection
|
№10 / 2021
|
|
Larina V.N.
Comorbid patient with chronic heart failure: possibilities of sacubitril/valsartan
|
№6 / 2021
|
Русский
